OnCo
technologiesTechnologyEmerging

Tempus multimodal models

Models trained on Tempus's paired genomic, pathology, imaging and outcome data to predict response and prognosis.

Tempus reports models for MSI, HRD and response prediction from H&E, ECG-based algorithms, and the Tempus One assistant; validation is largely internal or in company publications.

Generic schematic · not to scale · placeholder for the ai computation front
Flagged finding · Neural network

How it works

Tempus trains supervised and self-supervised multimodal models on a proprietary clinico-genomic corpus.

Strengths
  • Paired real-world data
Limitations
  • Proprietary; limited external validation
Since
2023

Latest papers

top
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this technology: (TITLE:"Tempus multimodal models" OR ABSTRACT:"Tempus multimodal models") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Tempus multimodal models, not a curated reading list.

Connected

3top

Pages like this

not linked directly; found by shared links